“Nontraditional Products for Bacterial Infections in Clinical Development”

“As of September 2017, an estimated 32 new nontraditional products with the potential to treat or prevent serious bacterial infections are in clinical development. Below is a snapshot of the current nontraditional products pipeline, based on publicly available information and informed by external experts. It is updated periodically as products advance or are known to drop out of development. Because this list is updated periodically, endnote numbers may not be sequential.”

Please contact abxpipeline@pewtrusts.org with additions or updates.

The September 2017 update can be downloaded here.

Source: The PEW Charitable Trust



What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed